1-4 of 4
Lucienne M. Ide
Close
Sort by
Journal Articles

FVIII Tolerance Following Nonmyeloablative Transplantation of Hematopoietic Stem Cells Engineered To Encode a High-Expression Factor VIII Transgene in Hemophilia A Mice.

Lucienne M. Ide, BA, Bagirath Gangadharan, MS, Christopher Doering, PhD, H. Trent Spencer, PhD
Journal: Blood
Blood (2007) 110 (11): 2599.
https://doi.org/10.1182/blood.V110.11.2599.2599
Published: 2007
Journal Articles

Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens

Lucienne M. Ide, Bagirath Gangadharan, Kuang-Yueh Chiang, Christopher B. Doering, H. Trent Spencer
Journal: Blood
Blood (2007) 110 (8): 2855–2863.
https://doi.org/10.1182/blood-2007-04-082602
Published: 2007
Includes: Supplemental data
Journal Articles

Post-Transplantation Immunosuppression Facilitates Sustained Expression of Porcine Factor VIII after Reduced-Intensity Transplantation of Genetically-Modified Stem Cells.

Lucienne M. Ide, Bagirath Gangadharan, K.Y. Chiang, MD,PhD, Christopher Doering, PhD, H. Trent Spencer, PhD
Journal: Blood
Blood (2006) 108 (11): 3280.
https://doi.org/10.1182/blood.V108.11.3280.3280
Published: 2006
Journal Articles

High-level expression of porcine factor VIII from genetically modified bone marrow–derived stem cells

Bagirath Gangadharan, Ernest T. Parker, Lucienne M. Ide, H. Trent Spencer, Christopher B. Doering
Journal: Blood
Blood (2006) 107 (10): 3859–3864.
https://doi.org/10.1182/blood-2005-12-4961
Published: 2006